James Mahon
Overview
Explore the profile of James Mahon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Offiah C, Tierney S, Egan B, Collins R, Ryan D, McCarthy A, et al.
Ir J Med Sci
. 2023 Apr;
192(6):3051-3062.
PMID: 37081289
Background/aims: Data are limited on the frequency of 'consensus decisions' between sub-specialists attending a neurovascular multidisciplinary meeting (MDM) regarding management of patients with extracranial carotid/vertebral stenoses and post-MDM 'adherence' to...
12.
Mahon J, Beale S, Holmes H, Arber M, Nikolayevskyy V, Alagna R, et al.
BMC Pulm Med
. 2022 Oct;
22(1):375.
PMID: 36199061
Background: The World Health Organisation (WHO) recommends that testing and treatment for latent tuberculosis infection (LTBI) should be undertaken in high-risk groups using either interferon gamma release assays (IGRAs) or...
13.
Jaishankar D, Cosgrove C, Ramesh P, Mahon J, Shivde R, Dellacecca E, et al.
Cell Stress Chaperones
. 2021 Sep;
26(5):845-857.
PMID: 34542825
Developing immunosuppressive therapies for autoimmune diseases comes with a caveat that immunosuppression may promote the risk of developing other conditions or diseases. We have previously shown that biolistic delivery of...
14.
Hounsome J, Pilkington G, Mahon J, Boland A, Beale S, Kotas E, et al.
Health Technol Assess
. 2020 Jun;
24(30):1-116.
PMID: 32589125
Background: Impacted third molars are third molars that are blocked, by soft tissue or bone, from fully erupting through the gum. This can cause pain and disease. The treatment options...
15.
Houten R, Greenhalgh J, Mahon J, Nevitt S, Beale S, Boland A, et al.
Pharmacoecon Open
. 2020 Apr;
5(1):13-22.
PMID: 32291725
As part of the Single Technology Appraisal process, the National Institute for Health and Care Excellence (NICE) invited Pierre Fabre to submit evidence for the clinical and cost-effectiveness of encorafenib...
16.
Duarte R, Stainthorpe A, Greenhalgh J, Richardson M, Nevitt S, Mahon J, et al.
Health Technol Assess
. 2020 Jan;
24(3):1-164.
PMID: 31933471
Background: Atrial fibrillation (AF) is the most common type of cardiac arrhythmia and is associated with an increased risk of stroke and congestive heart failure. Lead-I electrocardiogram (ECG) devices are...
17.
Duarte R, Stainthorpe A, Mahon J, Greenhalgh J, Richardson M, Nevitt S, et al.
PLoS One
. 2019 Dec;
14(12):e0226671.
PMID: 31869370
Background: Atrial fibrillation (AF) is the most common type of cardiac arrhythmia and is associated with increased risk of stroke and congestive heart failure. Lead-I electrocardiogram (ECG) devices are handheld...
18.
Power C, Duffy R, Mahon J, McCarroll K, Lawlor B
J Geriatr Psychiatry Neurol
. 2019 Nov;
33(6):340-352.
PMID: 31665962
Osteoporotic fractures are associated with major morbidity and mortality, particularly among older age groups. In recent decades, selective serotonin reuptake inhibitors (SSRI) antidepressants have been linked to reduced bone mineral...
19.
Fleeman N, Mahon J, Nevitt S, Duarte R, Boland A, Kotas E, et al.
Pharmacoecon Open
. 2019 Jun;
3(4):453-461.
PMID: 31240690
As part of the Single Technology Appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer of cenegermin (OXERVATE, Dompé) to submit evidence for the...
20.
Lambe T, Duarte R, Mahon J, Nevitt S, Greenhalgh J, Boland A, et al.
Pharmacoeconomics
. 2018 Oct;
37(3):345-357.
PMID: 30328051
As part of the single technology appraisal process, the National Institute for Health and Care Excellence invited Merck to submit evidence for the clinical and cost effectiveness of cladribine tablets...